Correlation Between Telo Genomics and Hemostemix

Can any of the company-specific risk be diversified away by investing in both Telo Genomics and Hemostemix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telo Genomics and Hemostemix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telo Genomics Corp and Hemostemix, you can compare the effects of market volatilities on Telo Genomics and Hemostemix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telo Genomics with a short position of Hemostemix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telo Genomics and Hemostemix.

Diversification Opportunities for Telo Genomics and Hemostemix

0.22

Correlation Coefficient

Telo Genomics  Hemostemix

Modest diversification

The 3 months correlation between Telo and Hemostemix is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Telo Genomics Corp and Hemostemix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hemostemix and Telo Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telo Genomics Corp are associated (or correlated) with Hemostemix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hemostemix has no effect on the direction of Telo Genomics i.e., Telo Genomics and Hemostemix go up and down completely randomly.

Pair Corralation between Telo Genomics and Hemostemix

Assuming the 90 days horizon Telo Genomics Corp is expected to generate 1.4 times more return on investment than Hemostemix. However, Telo Genomics is 1.4 times more volatile than Hemostemix. It trades about 0.03 of its potential returns per unit of risk. Hemostemix is currently generating about 0.03 per unit of risk. If you would invest  11.00  in Telo Genomics Corp on September 19, 2024 and sell it today you would lose (2.93) from holding Telo Genomics Corp or give up 26.64% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Telo Genomics Corp  vs.  Hemostemix

Telo Genomics Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Hemostemix

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Hemostemix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Hemostemix showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telo Genomics and Hemostemix

The main advantage of trading using opposite Telo Genomics and Hemostemix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telo Genomics position performs unexpectedly, Hemostemix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemostemix will offset losses from the drop in Hemostemix's long position.

The idea behind Telo Genomics Corp and Hemostemix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..